Mail-Order Giant Medco Courting Drug Firms
- Share via
NEW YORK — Medco Containment Services Inc., the largest provider of mail-order prescription drugs to members of health plans, said Tuesday that it has been talking to several pharmaceutical companies about a linkup.
Although speculation mounted that industry giant Merck & Co. was a suitor, analysts said an acquisition by the drug company was unlikely. Merck was silent.
Investors, hedging their bets, bid Medco’s stock up anyway, and it gained $1.375 to close Tuesday at $30.125 in NASDAQ trading.
Medco, based in Montvale, N.J., said it “has been engaging in strategic talks with several pharmaceutical companies.”
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
